急性肝炎E与肝纤维化并发症:一例病例报告
Xin-Yue Liu1, Hui-Ying Rao2, Rui Huang2
1Department of Nephrology,Peking University People's Hospital,Beijing 100044,China.
Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae
|September 15, 2025
概括
肝炎E可以引起肝脏炎症. 在免疫能力强的成年人中,氨基转移酶的升高可能表明肝纤维化,需要医生评估,特别是那些患有慢性肝病的人.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 肝炎E是一种由肝炎E病毒 (HEV) 引起的肝炎.
- 免疫能力强的人经常清除HEV感染,而免疫抑制患者则面临慢性肝炎的风险.
- 大多数HEV感染无症状或引起轻度肝功能异常.
研究的目的:
- 在免疫能力强的成年人中报告肝炎E病例.
- 要突出提升的氨基转移酶作为一个关键的表现.
- 强调在急性肝炎E时评估肝纤维化的重要性.
主要方法:
- 一个免疫能力强的成年人患有E型肝炎的病例报告.
- 生物化学分析显示了氨基转移酶的升高.
- 肝脏穿刺活检以评估肝脏组织学.
主要成果:
- 这位患者呈现了氨基转移酶的升高,这是肝炎E的主要症状.
- 肝纤维化通过肝活检确定.
- 这一案例强调了免疫能力强的主体的潜在并发症.
结论:
- 在免疫能力较强的成年人中,急性肝炎E可呈现出明显的肝酶升高.
- 在评估急性肝炎E时,应考虑肝纤维化.
- 在急性肝炎E患者中,医生应保持对肝纤维化的高度怀疑指数,特别是那些有先前存在的慢性肝病患者.
相关概念视频
Ultrasound II: Endoscopic Ultrasound and FibroScan
565
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
565
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
185
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
185
Diseases of the Liver and Gallbladder
1.9K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.9K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
215
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
215


